Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Electra Gruppen in connection with the merger with Elon Group
Mandate

Vinge advises Electra Gruppen in connection with the merger with Elon Group

December 09, 2021 EU, Competition and Regulatory Capital Markets and Public M&A

Electra Gruppen, listed on Nasdaq Stockholm, develops and operates concepts for retail chains with independent entrepreneurs, especially within consumer electronics, and is a flexible logistics partner that offers advanced IT and logistics solutions. Electra Gruppen’s merger with Elon Group creates the leading voluntary specialist retail chain in the Nordic region for home products with a focus on kitchens, appliances, consumer electronics, lighting and interior design, offered to consumers and businesses.

Based on the closing price of Electra Gruppen’s share on 6 December 2021 of SEK 65.0 per share, the value of the Electra Gruppen shares issued amounts to approximately SEK 628 million. The merger is intended to be carried out during the first half of 2022.

The Vinge team has primarily consisted of Charlotte Levin, Erik Sjöman, Amanda Knutsson, Annika Nyberg Ekenberg (Corporate public), samt Johan Karlsson, Sebastian Örndahl och Jakob Jeanrond (EU and competition).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025